Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity.

Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity.

Item
http://www.wikidata.org/entity/Q40561886
Immunogenicity of therapeutic recombinant immunotoxins.Immuno-targeting the multifunctional CD38 using nanobodyEmerging antibody-drug conjugates for treating lymphoid malignancies.Rational design of low immunogenic anti CD25 recombinant immunotoxin for T cell malignancies by elimination of T cell epitopes in PE38.Production and quality control assessment of a GLP-grade immunotoxin, D2C7-(scdsFv)-PE38KDEL, for a phase I/II clinical trial.Immunotoxins in cancer therapy: Review and update.The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer.Human T-Cell Leukemia Virus Type 1 Infection and Adult T-Cell Leukemia.A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment Strategies.Improving the in vivo efficacy of an anti-Tac (CD25) immunotoxin by Pseudomonas exotoxin A domain II engineering.
P2860

Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity.

Item
http://www.wikidata.org/entity/Q40561886
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Complete Remissions of Adult T ...... erapy to Block Immunogenicity.
@en
type
label
Complete Remissions of Adult T ...... erapy to Block Immunogenicity.
@en
prefLabel
Complete Remissions of Adult T ...... erapy to Block Immunogenicity.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Complete Remissions of Adult T ...... erapy to Block Immunogenicity.
@en
P2093
P304
P31
P356
10.1158/1078-0432.CCR-15-1412
P407
P433
P478
P577
P698
P932